This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by CÁMARA, A. A. Articles by SCHEMM, F. R. Search for Related Content PubMed PubMed Citation Articles by CÁMARA, A. A. Articles by SCHEMM, F. R. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Failure

(Circulation. 1955;11:702.)
© 1955 American Heart Association, Inc.

---

Corticotropin (ACTH) in Heart Disease: Its Paradoxical Effect on Sodium Excretion in Resistant Congestive Failure

AUGUSTO A. CÁMARA M.D.¹ FERDINAND R. SCHEMM M.D.¹

¹ From the Metabolic Unit, Montana Deaconess Hospital and the Department of Medicine of the Great Falls Clinic, Great Falls, Montana.

Since the spring of 1952 we have undertaken a clinical trial of corticotropin in 21 cardiac patients with resistant edema. Of these, there were eight with arteriosclerotic, eight with chronic rheumatic, and three with hypertensive heart disease, while two had cor pulmonale. Beneficial results were obtained in 17, or 81 per cent of the cases. These consisted of a spontaneous diuresis either during corticotropin administration or after its withdrawal, or an alteration of response to mercurials, the patients subsequently responding favorably, whereas they had previously been completely refractory to the mercurial diuretics.

This article has been cited by other articles:

				M. Vainder Idiopathic Lymphedema Treatment With Adrenal Steroids Angiology, October 1, 1963; 14(10): 524 - 528. [PDF]